Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 2 TO FORM S-1 - MARRONE BIO INNOVATIONS INC | d329931ds1a.htm |
| EX-3.2 - EX-3.2 - MARRONE BIO INNOVATIONS INC | d329931dex32.htm |
| EX-3.4 - EX-3.4 - MARRONE BIO INNOVATIONS INC | d329931dex34.htm |
| EX-4.1 - EX-4.1 - MARRONE BIO INNOVATIONS INC | d329931dex41.htm |
| EX-5.1 - EX-5.1 - MARRONE BIO INNOVATIONS INC | d329931dex51.htm |
| EX-10.4 - EX-10.4 - MARRONE BIO INNOVATIONS INC | d329931dex104.htm |
| EX-10.3 - EX-10.3 - MARRONE BIO INNOVATIONS INC | d329931dex103.htm |
| EX-21.1 - EX-21.1 - MARRONE BIO INNOVATIONS INC | d329931dex211.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 17, 2013, in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-189753) and related Prospectus of Marrone Bio Innovations, Inc. for the registration of 4,830,000 shares of its common stock.
/s/ Ernst & Young LLP
Sacramento, California
July 19, 2013